MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$14,831K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from long-term debt and...
(gain) loss on divestitures, net
Proceeds from sale of businesses...
Others
Negative Cash Flow Breakdown
Acquisition of businesses and as...
Payments on long-term debt, revo...
Purchase of treasury stock
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-28
2025-12-27
2025-09-27
2025-06-28
Net income (loss)
-14,802
-276,290
55,556
52,693
Depreciation and amortization
67,151
78,277
85,164
119,507
Goodwill impairment
-
165,000
-
-
Long-lived asset impairments
15,863
222,895
4,982
20,627
Stock-based compensation
22,381
17,632
23,267
17,049
Deferred income taxes
-29,417
-60,170
25,908
-21,989
Write down of inventories
1,489
1,747
-370
4,305
(gain) loss on venture capital and strategic equity investments, net
-
-
-
-2,525
Losses and impairments on venture capital and strategic equity investments, net
-1,138
9,044
-33,955
-
Provision for credit losses
47
1,503
2,368
184
(gain) loss on divestitures, net
-117,981
0
0
0
Other, net
34,675
802
-1,040
1,465
Trade receivables and contract assets, net
65,319
-27,631
-26,596
-10,863
Inventories
-26,004
3,497
31,327
-7,929
Accounts payable
20,455
-37,878
24,506
-9,010
Accrued compensation
-83,758
-2,562
42,880
23,727
Deferred revenue
5,197
-25,820
-23,625
12,519
Customer contract deposits
-135
15,185
-1,101
-8,599
Other assets and liabilities, net
8,523
-33,713
43,074
26,262
Net cash provided by operating activities
41,077
147,520
213,826
204,603
Acquisition of businesses and assets, net of cash acquired
405,006
0
0
0
Capital expenditures
55,908
88,950
35,580
35,298
Purchases of investments and contributions to venture capital investments
8,492
7,532
4,454
2,788
Proceeds from sale of investments
2,922
3,465
3,531
504
Proceeds from sale of businesses and assets, net
60,096
0
0
0
Other, net
1,457
-210
-2,807
-243
Net cash used in investing activities
-407,845
-92,807
-33,696
-37,339
Proceeds from long-term debt and revolving credit facility
912,462
156,673
107,498
547,022
Payments on long-term debt, revolving credit facility, and finance lease obligations
355,676
207,817
253,794
738,312
Proceeds from exercises of stock options
1,223
711
2
1
Purchase of treasury stock
208,285
96
93
7,352
Payments of contingent consideration
-
0
0
21,822
Purchase of remaining equity interest of other redeemable noncontrolling interests
0
0
0
0
Other, net
-2,000
-1,335
-6,229
-6,458
Net cash provided by (used in) financing activities
347,724
-51,864
-152,616
-226,921
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
1,248
3,928
-3,034
12,669
Net change in cash, cash equivalents, and restricted cash
-17,796
6,777
24,480
-46,988
Cash, cash equivalents, and restricted cash, beginning of period
215,997
231,728
231,728
231,728
Cash, cash equivalents, and restricted cash, end of period
198,201
215,997
209,220
184,740
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from long-term
debt and revolving...
$912,462K
(119.16%↑ Y/Y)
(gain) loss on
divestitures, net
-$117,981K
(-3594.70%↓ Y/Y)
Proceeds from exercises
of stock options
$1,223K
Depreciation and
amortization
$67,151K
(-44.21%↓ Y/Y)
Inventories
-$26,004K
(-218.84%↓ Y/Y)
Stock-based compensation
$22,381K
(70.39%↑ Y/Y)
Accounts payable
$20,455K
(-18.99%↓ Y/Y)
Long-lived asset
impairments
$15,863K
(49.99%↑ Y/Y)
Deferred revenue
$5,197K
(528.44%↑ Y/Y)
Write down of
inventories
$1,489K
(-77.98%↓ Y/Y)
Losses and impairments
on venture capital...
-$1,138K
Provision for credit
losses
$47K
(-97.66%↓ Y/Y)
Net cash provided by
(used in) financing...
$347,724K
(430.14%↑ Y/Y)
Net cash provided by
operating activities
$41,077K
(-76.08%↓ Y/Y)
Effect of exchange rate
changes on cash, cash...
$1,248K
(-76.30%↓ Y/Y)
Canceled cashflow
$565,961K
Canceled cashflow
$236,629K
Net change in cash,
cash equivalents,...
-$17,796K
(-168.03%↓ Y/Y)
Canceled cashflow
$390,049K
Proceeds from sale of
businesses and assets, net
$60,096K
(244.57%↑ Y/Y)
Proceeds from sale of
investments
$2,922K
(82.40%↑ Y/Y)
Payments on long-term
debt, revolving...
$355,676K
(138.08%↑ Y/Y)
Purchase of treasury
stock
$208,285K
(-41.02%↓ Y/Y)
Other, net
-$2,000K
Accrued compensation
-$83,758K
(-648.76%↓ Y/Y)
Trade receivables and
contract assets, net
$65,319K
(122.53%↑ Y/Y)
Other, net
$34,675K
(1029.38%↑ Y/Y)
Deferred income taxes
-$29,417K
(-54.49%↓ Y/Y)
Net income (loss)
-$14,802K
(-157.20%↓ Y/Y)
Other assets and
liabilities, net
$8,523K
(310.24%↑ Y/Y)
Customer contract
deposits
-$135K
(-101.47%↓ Y/Y)
Net cash used in
investing activities
-$407,845K
(-796.78%↓ Y/Y)
Canceled cashflow
$63,018K
Acquisition of businesses
and assets, net of...
$405,006K
Capital expenditures
$55,908K
(-5.76%↓ Y/Y)
Purchases of investments
and contributions...
$8,492K
(60.17%↑ Y/Y)
Other, net
$1,457K
(1500.96%↑ Y/Y)
Buy us a coffee
CRL_BIG
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CRL_BIG
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)